Purpose: To determine if topical beta-blocker use is associated with increased
cardiovascular mortality, particularly among people with self-reported glaucoma. Methods …

Objective:-To evaluate prescription patterns for patients seeking consultation for various
types and subtypes of primary glaucoma. Methods:-It was an observational study of one year …

A patient presented to our clinic with stage Ia open-angle glaucoma of the right eye and
stage IIa surgically corrected open-angle glaucoma of the left eye. The condition of the …

The study represent an up-to-date of the role and place of alpha 2-adrenergic agonists in
glaucoma treatment. The first available alpha 2-agonist, clonidine is of historical importance …

In glaucoma treatment, beside the traditional reduction of intraocular pressure, additional
therapeutic strategies have come into consideration. Therefore pleiotropic effects of …

Purpose: To investigate the use of topical ocular anti-glaucoma medications by
glaucomatous patients with obstructive pulmonary disease and their effect on related …

In a prospective, randomized, double-masked study, 44 patients with primary open-angle
glaucoma were treated either with 0.5% betaxolol or 0.5% timolol in both eyes twice daily …

Topically administered beta blockers are the preferred medical therapy for glaucoma. These
agents reduce intraocular pressure (IOP), thereby preventing damage to the optic nerve and …

With the emergence of prostaglandin analogs, beta-blockers have been challenged as the
initial treatment for glaucoma. It should be remembered that their clinical efficacy in reducing …

We report the possibility of treatment with beta-adrenergic blocking agents in glaucoma-
therapy. In open-angle glaucoma the therapy with beta-adrenergic blocking agents is often …